Where I see patients (1)
My reviews
4.9
Selected research
-
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models.
Blood advances
-
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.
Cell reports
-
Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling.
Cell reports
Contact me
- Request appointment
- Refer a patient
- (415) 353-7070